Mays Cancer Center

Clinical research site in San Antonio, Texas · 7979 WURZBACH RD, SAN ANTONIO, TX 78229-4427 · (210) 450-1000 · Website

As of July 2026, 19 paid clinical trials are recruiting at Mays Cancer Center in San Antonio, Texas. Active studies at this site cover conditions such as Breast Cancer, Breast Neoplasms and Triple-Negative Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Mays Cancer Center (19)

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for Breast Cancer

169 locations incl. Daphne

Sponsor: Stemline Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for Breast Neoplasms

34 locations incl. Daphne

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07060807·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for Triple-Negative Breast Cancer

81 locations incl. Mobile

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06393374·Phase 3·Recruiting·Listed May 2024

Apply to this trial

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for Glioma

42 locations incl. Birmingham

Sponsor: Nuvation Bio Inc.

Sex: All·Age: 18+

Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022

Apply to this trial

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

for Metastatic Urothelial Cancer

27 locations incl. Tucson

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT03547973·Phase 2·Recruiting·Listed Jun 2018

Apply to this trial

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

for Non-small Cell Lung Cancer

17 locations incl. Little Rock

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06422143·Phase 3·Recruiting·Listed May 2024

Apply to this trial

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

for Small Cell Lung Cancer (SCLC)

15 locations incl. Duarte

Sponsor: Phanes Therapeutics

Sex: All·Age: 18+

Code: NCT05652686·Phase 1, Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

SLV-154 Treatment of Metastatic Solid Tumors

for Squamous Cell Cancer of Head and Neck (SCCHN)

10 locations incl. Newport Beach

Sponsor: Solve Therapeutics

Sex: All·Age: 18+

Code: NCT06771219·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

for Breast Cancer

22 locations incl. Duarte

Sponsor: Celcuity Inc

Sex: All·Age: 18+

Code: NCT06757634·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

for Malignant Neoplasm

10 locations incl. Anchorage

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06979596·Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

for Colorectal Cancer

9 locations incl. New Haven

Sponsor: Criterium, Inc.

Sex: All·Age: 18+

Code: NCT06992258·Phase 2·Recruiting·Listed May 2025

Apply to this trial

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

for Advanced or Metastatic Solid Tumors

4 locations incl. Tampa

Sponsor: Hanmi Pharmaceutical Company Limited

Sex: All·Age: 18+

Code: NCT06234397·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Impact of Ketogenic Diet on Tumor Microenvironment in Patients With Breast Cancer

for Breast Cancer

1 location in San Antonio

Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All·Age: 18+

Code: NCT07574671·Recruiting·Listed May 2026

Apply to this trial

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

for Leukemia

3 locations incl. Miami

Sponsor: University of Miami

Sex: All·Age: 18+

Code: NCT05745285·Recruiting·Listed Feb 2023

Apply to this trial

Wellness App for Sleep Disturbance in Hematological Cancer Patients

for Cancer

2 locations incl. Winston-Salem

Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All·Age: 18+

Code: NCT05294991·Recruiting·Listed Mar 2022

Apply to this trial

Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

for Breast Cancer Metastatic

1 location in San Antonio

Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All·Age: 18+

Code: NCT07137871·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

for Carcinoma, Hepatocellular

1 location in San Antonio

Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All·Age: 18+

Code: NCT03894917·Recruiting·Listed Mar 2019

Apply to this trial

Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)

for Hepatocellular Carcinoma

3 locations incl. Pittsburgh

Sponsor: Anwaar Saeed

Sex: All·Age: 18+

Code: NCT06698250·Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

for Glioblastoma

1 location in San Antonio

Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All·Age: All ages

Code: NCT04863950·Phase 2·Recruiting·Listed Apr 2021

Apply to this trial

More research sites in San Antonio

University of Texas Health Science Center at San Antonio (85 trials)
NEXT Oncology (56 trials)
Children's Hospital of San Antonio (32 trials)
Methodist Children's Hospital of South Texas (24 trials)
START San Antonio (22 trials)
The University of Texas Health Science Center at San Antonio (21 trials)
UT Health San Antonio (16 trials)
GSK Investigational Site (13 trials)
Texas Dermatology and Laser Specialists (13 trials)
Texas Oncology - San Antonio (12 trials)

Explore more

Paid clinical trials in San Antonio, TX · Texas clinical trials